Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Beam Therapeutics Inc. BEAM

Full chart Compare
Set alert

Price alert · BEAM

All alert types
26.49 USD +0.62 (+2.40%)

Nov 3, 2026, 3:15 PM EST

25.99 Day range 27.20
20.23 52-week range 38.26
YTD
-4.43%
1 year
+9.24%

Financial health

Altman Z-Score

3.62 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -34.2×
FY 2017: -30.2×FY 2018: -5.7×FY 2019: -12.3×FY 2020: -14.9×FY 2021: -13.8×FY 2022: -9.5×FY 2023: -15.8×FY 2024: -5.4×FY 2025: -34.2×
FY 2017 5y median -13.8× FY 2025
P/S 19.6×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 53479×FY 2020: 158971×FY 2021: 98.7×FY 2022: 44.9×FY 2023: 5.6×FY 2024: 32.1×FY 2025: 19.6×
FY 2017 5y median 32.1× FY 2025
P/B 2.2×
FY 2017: -58.1×FY 2018: 4.9×FY 2019: 9.5×FY 2020: 15.5×FY 2021: 6.2×FY 2022: 3.7×FY 2023: 2.1×FY 2024: 2.8×FY 2025: 2.2×
FY 2017 5y median 2.8× FY 2025
P/FCF -7.6×
FY 2017: -79.6×FY 2018: -19.7×FY 2019: -11.4×FY 2020: -34.0×FY 2021: -45.3×FY 2022: -104×FY 2023: -11.5×FY 2024: -5.7×FY 2025: -7.6×
FY 2017 5y median -11.5× FY 2025
EV/EBITDA -196×
FY 2017: -28.2×FY 2018: -11.4×FY 2019: -13.4×FY 2020: -29.4×FY 2021: -20.5×FY 2022: -9.9×FY 2023: -16.5×FY 2024: -5.4×FY 2025: -196×
FY 2017 5y median -16.5× FY 2025
EV/Sales 19.6×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 53146×FY 2020: 156699×FY 2021: 90.8×FY 2022: 44.1×FY 2023: 4.9×FY 2024: 30.2×FY 2025: 19.6×
FY 2017 5y median 30.2× FY 2025
FCF Yield -13.1%
FY 2017: -1.3%FY 2018: -5.1%FY 2019: -8.8%FY 2020: -2.9%FY 2021: -2.2%FY 2022: -1.0%FY 2023: -8.7%FY 2024: -17.4%FY 2025: -13.1%
FY 2017 5y median -8.7% FY 2025

Profitability

Gross Margin 84.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -303338.9%FY 2020: -429812.5%FY 2021: -347.8%FY 2022: -411.5%FY 2023: 100.0%FY 2024: -478.7%FY 2025: 84.0%
FY 2017 5y median -347.8% FY 2025
Operating Margin -274.6%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -417522.2%FY 2020: -553166.7%FY 2021: -757.0%FY 2022: -555.6%FY 2023: -46.7%FY 2024: -654.3%FY 2025: -274.6%
FY 2017 5y median -555.6% FY 2025
Net Margin -57.2%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -435144.4%FY 2020: -810800.0%FY 2021: -714.9%FY 2022: -474.5%FY 2023: -35.1%FY 2024: -593.1%FY 2025: -57.2%
FY 2017 5y median -474.5% FY 2025
ROE -6.5%
FY 2017: 208.7%FY 2018: -86.0%FY 2019: -77.6%FY 2020: -79.2%FY 2021: -44.8%FY 2022: -39.4%FY 2023: -13.5%FY 2024: -51.4%FY 2025: -6.5%
FY 2017 5y median -39.4% FY 2025
ROIC -27.4%
FY 2017: 272.6%FY 2018: -32.3%FY 2019: -56.7%FY 2020: -37.3%FY 2021: -30.9%FY 2022: -30.0%FY 2023: -13.9%FY 2024: -44.4%FY 2025: -27.4%
FY 2017 5y median -30.0% FY 2025
ROA -5.4%
FY 2017: -363.4%FY 2018: -69.0%FY 2019: -50.2%FY 2020: -43.1%FY 2021: -25.1%FY 2022: -21.5%FY 2023: -9.1%FY 2024: -34.1%FY 2025: -5.4%
FY 2017 5y median -21.5% FY 2025

Growth (YoY)

Revenue 120.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 33.3%FY 2021: 215916.7%FY 2022: 17.5%FY 2023: 520.0%FY 2024: -83.2%FY 2025: 120.0%
FY 2017 FY 2025
Operating Income 7.7%
FY 2017: 0.0%FY 2018: -432.1%FY 2019: -64.3%FY 2020: -76.7%FY 2021: -195.6%FY 2022: 13.8%FY 2023: 47.9%FY 2024: -135.5%FY 2025: 7.7%
FY 2017 FY 2025
EPS (diluted) 82.3%
FY 2017: 0.0%FY 2018: -429.0%FY 2019: 53.4%FY 2020: -258.8%FY 2021: -5.1%FY 2022: 28.4%FY 2023: 58.4%FY 2024: -166.3%FY 2025: 82.3%
FY 2017 FY 2025
Free Cash Flow -1.1%
FY 2017: 0.0%FY 2018: -994.7%FY 2019: -152.9%FY 2020: -32.6%FY 2021: -0.9%FY 2022: 76.6%FY 2023: -592.3%FY 2024: -94.7%FY 2025: -1.1%
FY 2017 FY 2025

Financial Health

Current Ratio 13.1×
FY 2017: 0.3×FY 2018: 5.8×FY 2019: 3.2×FY 2020: 3.0×FY 2021: 6.0×FY 2022: 4.9×FY 2023: 5.9×FY 2024: 4.8×FY 2025: 13.1×
FY 2017 5y median 5.9× FY 2025
Quick Ratio 13.1×
FY 2017: 0.3×FY 2018: 5.8×FY 2019: 3.2×FY 2020: 3.0×FY 2021: 6.0×FY 2022: 4.9×FY 2023: 5.9×FY 2024: 4.8×FY 2025: 13.1×
FY 2017 5y median 5.9× FY 2025
Debt / Equity 0.2×
FY 2017: -0.2×FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.4×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.2×
FY 2017 5y median 0.2× FY 2025
Net Debt / EBITDA 0.1×
FY 2017: 0.1×FY 2018: 3.2×FY 2019: 0.1×FY 2020: 0.4×FY 2021: 1.8×FY 2022: 0.2×FY 2023: 2.4×FY 2024: 0.3×FY 2025: 0.1×
FY 2017 5y median 0.3× FY 2025
Interest Coverage -8.8×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -402×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -8.8×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31